Shopping Cart 0
Cart Subtotal
USD 0

Generics in South Africa

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in South Africa

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Africa

Leading company profiles reveal details of key generics market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the South Africa generics market with five year forecasts by both value and volume

Synopsis

Essential resource for top-line data and analysis covering the South Africa generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons to Buy

What was the size of the South Africa generics market by value in 2016?

What will be the size of the South Africa generics market in 2021?

What factors are affecting the strength of competition in the South Africa generics market?

How has the market performed over the last five years?

How large is South Africa's generics market in relation to its regional counterparts?

Key Highlights

For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The South African generics market is expected to generate total revenues of $637m in 2016, representing a compound annual growth rate (CAGR) of 5.9% between 2012 and 2016.

Market consumption volume is forecast to increase with a CAGR of 3% between 2012 and 2016, to reach a total of 82.5% of total pharma volume in 2016.

The government is showing strong support for generic drugs in Africa, which should see good growth in the future. For example, pharmacists are required by law to inform private patients about generic alternatives.

READ MORE

Table Of Content

Scope

Executive Summary

Market value

Market value forecast

Market volume

Market volume forecast

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market volume

Market Segmentation

Geography segmentation

Market Outlook

Market value forecast

Market volume forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Adcock Ingram Holdings Limited

Aspen Pharmacare Holdings Ltd

Teva Pharmaceutical Industries Limited

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

Figure 1: South Africa generics market value: $ billion, 2012-16(e)

Figure 2: South Africa generics market volume: % of total pharma volume, 2012-16(e)

Figure 3: South Africa generics market geography segmentation: % share, by value, 2016(e)

Figure 4: South Africa generics market value forecast: $ billion, 2016-21

Figure 5: South Africa generics market volume forecast: % of total pharma volume, 2016-21

Figure 6: Forces driving competition in the generics market in South Africa, 2016

Figure 7: Drivers of buyer power in the generics market in South Africa, 2016

Figure 8: Drivers of supplier power in the generics market in South Africa, 2016

Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2016

Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2016

Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2016

Figure 12: Adcock Ingram Holdings Limited: revenues & profitability

Figure 13: Adcock Ingram Holdings Limited: assets & liabilities

Figure 14: Aspen Pharmacare Holdings Ltd: revenues & profitability

Figure 15: Aspen Pharmacare Holdings Ltd: assets & liabilities

Figure 16: Teva Pharmaceutical Industries Limited: revenues & profitability

Figure 17: Teva Pharmaceutical Industries Limited: assets & liabilities


List Of Table

Table 1: South Africa generics market value: $ billion, 2012-16(e)

Table 2: South Africa generics market volume: % of total pharma volume, 2012-16(e)

Table 3: South Africa generics market geography segmentation: $ billion, 2016(e)

Table 4: South Africa generics market value forecast: $ billion, 2016-21

Table 5: South Africa generics market volume forecast: % of total pharma volume, 2016-21

Table 6: Adcock Ingram Holdings Limited: key facts

Table 7: Adcock Ingram Holdings Limited: key financials ($)

Table 8: Adcock Ingram Holdings Limited: key financials (ZAR)

Table 9: Adcock Ingram Holdings Limited: key financial ratios

Table 10: Aspen Pharmacare Holdings Ltd: key facts

Table 11: Aspen Pharmacare Holdings Ltd: key financials ($)

Table 12: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 13: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 14: Teva Pharmaceutical Industries Limited: key facts

Table 15: Teva Pharmaceutical Industries Limited: key financials ($)

Table 16: Teva Pharmaceutical Industries Limited: key financial ratios

Table 17: South Africa size of population (million), 2012-16

Table 18: South Africa gdp (constant 2005 prices, $ billion), 2012-16

Table 19: South Africa gdp (current prices, $ billion), 2012-16

Table 20: South Africa inflation, 2012-16

Table 21: South Africa consumer price index (absolute), 2012-16

Table 22: South Africa exchange rate, 2012-16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Generics, MarketLine, South Africa


Companies

Adcock Ingram Holdings Limited, Aspen Pharmacare Holdings Ltd, Teva Pharmaceutical Industries Limited